Coherus Oncology, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Redwood City, CA
CHRS chart
What traders are saying about $CHRS
Latest postsCoherus Oncology, Inc. news
- Coherus Oncology: 3 Key Takeaways for Long-Term Investors
fool.com ·
- Coherus Oncology (CHRS) Q3 2026 Earnings Call Transcript
fool.com ·
- Coherus Oncology (CHRS) Targets Financial Self-Sufficiency by 2027 with Strategic Focus on LOQTORZI
GuruFocus ·
- What Coherus Oncology (CHRS) Said on Its Q3 Earnings Call
marketbeat.com ·
- Coherus Oncology - Reduces Headcount By About 30%
TradingView ·
- Coherus Oncology, Inc. (CHRS) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance ·
- Coherus Oncology Reports Q3 2026 Results: Revenue of $14.3 Milli
GuruFocus ·
- Coherus Oncology Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Coherus Oncology Q3 2026 Earnings Call Is Live
TradingView ·
- Coherus Oncology: Q3 Earnings Snapshot
Yahoo Finance ·
- Coherus Oncology earnings matched, revenue fell short of estimates By Investing.com
Investing.com UK ·
Coherus Oncology, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $168.0M | $28.5M | -$237.9M | -$291.8M |
| Diluted EPS | $1.43 | $0.25 | $-2.53 | $-3.76 |
| Total assets (year end) | $258.3M | $448.5M | $629.6M | $480.8M |
| Cash and equivalents (year end) | $88.9M | $126.0M | $102.9M | $63.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Coherus Oncology, Inc.
- Ticker
- CHRS (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Redwood City, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1512762
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
Frequently asked questions
What exchange is Coherus Oncology, Inc. listed on?
Coherus Oncology, Inc. trades on the Nasdaq under the ticker symbol CHRS.
What industry is Coherus Oncology, Inc. in?
Coherus Oncology, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Coherus Oncology, Inc. headquartered?
Coherus Oncology, Inc.'s business address on file with the SEC is in Redwood City, CA.
When does Coherus Oncology, Inc.'s fiscal year end?
Coherus Oncology, Inc.'s fiscal year ends on December 31.
How much revenue did Coherus Oncology, Inc. report?
Coherus Oncology, Inc. reported $0 in revenue for calendar year 2018, according to its SEC filings.